ABBV
39
2
CHRW
64
8
MNST
65
3
VIX
65
-6
LH
32
-11
MDLZ
57
2
DFS
53
6
HP
34
5
EXR
48
6
PLD
43
3
EXPD
34
5
RCL
64
2
RF
56
2
APA
28
4
HAL
48
5
ESS
40
3
UPS
22
7
HIG
70
2
MLM
60
3
F
51
3
ABBV
39
2
CHRW
64
8
MNST
65
3
VIX
65
-6
LH
32
-11
MDLZ
57
2
DFS
53
6
HP
34
5
EXR
48
6
PLD
43
3
EXPD
34
5
RCL
64
2
RF
56
2
APA
28
4
HAL
48
5
ESS
40
3
UPS
22
7
HIG
70
2
MLM
60
3
F
51
3
Financhill
Back

Zevra Therapeutics Stock Price Chart

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
27

ZVRA
Zevra Therapeutics

Last Price:
$7.16
Seasonality Move:
-7.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVRA is experiencing slight buying pressure.

Zevra Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 6.88 Buy
20-day SMA: 7.35 Sell
50-day SMA: 7.66 Sell
200-day SMA: 7.69 Sell
8-day EMA: 7.03 Buy
20-day EMA: 7.25 Sell
50-day EMA: 7.59 Sell
200-day EMA: 7.47 Sell

Zevra Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 45.68 Sell
Chaikin Money Flow: 149600 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.96 - 8.06) Sell
Bollinger Bands (100): (7.43 - 8.77) Sell

Zevra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Zevra Therapeutics Stock

Is Zevra Therapeutics Stock a Buy?

  • Zevra Therapeutics share price is 7.15 while ZVRA 8-day simple moving average is 6.88, which is a Buy signal.
  • The stock price of ZVRA is 7.15 while Zevra Therapeutics 20-day SMA is 7.35, which makes it a Sell.
  • Zevra Therapeutics 50-day simple moving average is 7.66 while ZVRA share price is 7.15, making it a Sell technically.
  • ZVRA stock price is 7.15 and Zevra Therapeutics 200-day simple moving average is 7.69, creating a Sell signal.

ZVRA Technical Analysis vs Fundamental Analysis

Sell
27
Zevra Therapeutics (ZVRA) is a Sell

Is Zevra Therapeutics a Buy or a Sell?

Zevra Therapeutics Stock Info

Market Cap:
386.9M
Price in USD:
7.15
Share Volume:
406.1K

Zevra Therapeutics 52-Week Range

52-Week High:
9.76
52-Week Low:
4.20
Sell
27
Zevra Therapeutics (ZVRA) is a Sell

Zevra Therapeutics Share Price Forecast

Is Zevra Therapeutics Stock a Buy?

  • Zevra Therapeutics share price is 7.15 while ZVRA 8-day exponential moving average is 7.03, which is a Buy signal.
  • The stock price of ZVRA is 7.15 while Zevra Therapeutics 20-day EMA is 7.25, which makes it a Sell.
  • Zevra Therapeutics 50-day exponential moving average is 7.59 while ZVRA share price is 7.15, making it a Sell technically.
  • ZVRA stock price is 7.15 and Zevra Therapeutics 200-day simple moving average is 7.47, creating a Sell signal.

Fundamental Analysis of Zevra Therapeutics

Is Zevra Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.54 per share.

Technical Analysis of Zevra Therapeutics

Should I short Zevra Therapeutics stock?

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.